{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:59:51Z","timestamp":1790099991706,"version":"4.0.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the incidence, mechanisms, and clinical implications of silicone oil droplet transmission during intravitreal anti\u2013vascular endothelial growth factor injections and to review strategies to mitigate contamination risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review of observational and review studies from PubMed and MEDLINE was conducted, focusing on incidence, contributing factors, and clinical outcomes of silicone oil contamination during IVIs. Specific attention was given to syringe design, storage conditions, variations among anti\u2013vascular endothelial growth factor agents, and injection techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The review found that prevalence is high in chronically injected eyes, although per-injection rates are low, often clustering because of syringe batches or techniques. Contributing factors include freeze\u2013thaw cycles, mechanical agitation, spray-siliconized low dead space syringes, and improper plunger handling, which can lead to asymptomatic droplets or symptomatic floaters. No severe complications such as endophthalmitis were reported. Hypotheses link silicone oil to ocular hypertension or inflammation via trabecular obstruction or immunogenic responses, but the reviewed studies show no direct evidence. Mitigation involves the use of silicone-free\/prefilled syringes, strict storage, gentle handling, and refined techniques such as priming and smooth plunger depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Silicone oil contamination during IVIs can be minimized through careful optimization of syringe design, handling practices, and injection techniques. Embracing silicone-free or low-silicone syringe systems, alongside meticulous procedural protocols, offers the potential to enhance the safety and clinical outcomes of intravitreal anti\u2013vascular endothelial growth factor therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004829","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:00:13Z","timestamp":1773086413000},"page":"1631-1643","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["SILICONE OIL MIGRATION DURING INTRAVITREAL ANTI\u2013VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS"],"prefix":"10.1097","volume":"46","author":[{"given":"Kavon","family":"Rahmani","sequence":"first","affiliation":[{"name":"Department of Opthalmology Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan;"},{"name":"Department of Ophthalmology Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Rajeswaren","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Hodges","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-4297","authenticated-orcid":false,"given":"Pradeepa","family":"Yoganathan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan;"},{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto School of Medicine, Toronto, Ontario, Canada;"},{"name":"Department of Ophthalmology, Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada; and"},{"name":"Department of Biomedical Sciences, University of Windsor, Windsor, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.oret.2019.05.017","article-title":"Visual acuity outcomes and anti-vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49 485 eyes","volume":"4","author":"Ciulla","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00006982-200607000-00021","article-title":"Silicone oil droplets following intravitreal injection","volume":"26","author":"Freund","year":"2006","journal-title":"Retina"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/IAE.0b013e31816c6868","article-title":"Intravitreal silicone oil droplets after intravitreal drug injections","volume":"28","author":"Bakri","year":"2008","journal-title":"Retina"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40942-019-0184-9","article-title":"Prevalence of silicone oil droplets in eyes treated with intravitreal injection","volume":"5","author":"Melo","year":"2019","journal-title":"Int J retina vitreous"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/aos.14743","article-title":"Silicone microbubbles after anti\u2010vascular endothelial growth factor injections in patients with wet age\u2010related macular degeneration: incidence, quantification and secondary optical coherence tomography artfacts","volume":"99","author":"Sanabria","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12886-022-02536-2","article-title":"Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF","volume":"22","author":"Garc\u00eda","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.oret.2024.09.008","article-title":"Intravitreal silicone oil with a silicone-free versus a siliconized syringe","volume":"9","author":"Santos","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamaophthalmol.2017.1815","article-title":"Incidence of presumed silicone oil droplets in the vitreous cavity after intravitreal bevacizumab injection with insulin syringes","volume":"135","author":"Khurana","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajoc.2017.07.009","article-title":"Silicone oil droplets following intravitreal bevacizumab injections","volume":"10","author":"Yu","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/ICB.0000000000000570","article-title":"Large silicone droplets after intravitreal bevacizumab (avastin)","volume":"13","author":"Avery","year":"2019","journal-title":"Retinal Cases Brief Rep"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"e000764","DOI":"10.1136\/bmjophth-2021-000764","article-title":"Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study","volume":"6","author":"Sivertsen","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2009.06.004","article-title":"SCORE study report 7: incidence of intravitreal silicone oil droplets associated with Staked-on versus luer cone syringe design","volume":"148","author":"Scott","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1167\/iovs.10-6431","article-title":"Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"100862","DOI":"10.1016\/j.preteyeres.2020.100862","article-title":"Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections","volume":"80","author":"Melo","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.xphs.2016.08.031","article-title":"Silicone migration from Baked-on silicone layers. Particle characterization in placebo and protein solutions","volume":"105","author":"Funke","year":"2016","journal-title":"J Pharm Sci"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/IAE.0000000000002947","article-title":"Particulate matter from syringes used for intravitreal injections","volume":"41","author":"Dounce","year":"2021","journal-title":"Retina"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/OPTH.S169044","article-title":"Prefilled syringes for intravitreal drug delivery","volume":"13","author":"Sassalos","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.xphs.2023.05.017","article-title":"Variables impacting silicone oil migration and biologics in prefilled syringes","volume":"112","author":"Gentile","year":"2023","journal-title":"J Pharm Sci"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.oret.2023.06.003","article-title":"Accuracy, precision, and residual volume of commonly used syringes for intravitreal injections and the impact on intraocular pressure","volume":"7","author":"Agra","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1038\/s41598-021-84158-0","article-title":"High particle variability across siliconized and oil-free syringes and needles from the same lots","volume":"11","author":"do Monte Agra","year":"2021","journal-title":"Sci Rep"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.oret.2020.07.021","article-title":"Prospective study of silicone oil microdroplets in eyes receiving intravitreal anti-vascular endothelial growth factor therapy in 3 different syringes","volume":"5","author":"Thompson","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/IAE.0000000000001028","article-title":"Experimental visualization and quantification of vitreous contamination following intravitreal injections","volume":"36","author":"Nakashizuka","year":"2016","journal-title":"Retina"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/s41433-020-0800-9","article-title":"Agitation of the syringe and release of silicone oil","volume":"34","author":"Dias J\u00fanior","year":"2020","journal-title":"Eye"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40942-022-00387-z","article-title":"Ocular inflammation after agitation of siliconized and silicone oil-free syringes: a randomized, double-blind, controlled clinical trial","volume":"8","author":"da Cruz","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"R25-20260922","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00417-008-0819-2","article-title":"Persistent ocular hypertension following intravitreal ranibizumab","volume":"246","author":"Bakri","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents","volume":"95","author":"Good","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R27-20260922","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874364101004010028","article-title":"Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis","volume":"4","author":"Sniegowski","year":"2010","journal-title":"Open Ophthalmol J"},{"key":"R28-20260922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/IJG.0b013e31820d7d19","article-title":"Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"21","author":"Tseng","year":"2012","journal-title":"J Glaucoma"},{"key":"R29-20260922","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1002\/jps.24573","article-title":"In vivo analysis of the potency of silicone oil microdroplets as immunological adjuvants in protein formulations","volume":"104","author":"Chisholm","year":"2015","journal-title":"J Pharm Sci"},{"key":"R30-20260922","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaophthalmol.2014.5650","article-title":"Postmarketing analysis of aflibercept-related sterile intraocular inflammation","volume":"133","author":"Hahn","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R31-20260922","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/IAE.0b013e3181bd2d51","article-title":"Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch","volume":"30","author":"Yamashiro","year":"2010","journal-title":"Retina"},{"key":"R32-20260922","doi-asserted-by":"crossref","first-page":"114209","DOI":"10.1016\/j.ejpb.2024.114209","article-title":"Polymeric microneedles for the eye: an overview of advances and ocular applications for minimally invasive drug delivery","volume":"197","author":"Mulkutkar","year":"2024","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:00:24Z","timestamp":1790096424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004829"}},"subtitle":["A Review of Clinical Evidence and Factors Related to Transmission"],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004829","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}